Veterinary Vaccines - An Exclusive Market Insight Report from RI Technologies

Hyderabad, Andhra Pradesh India (PressExposure) November 17, 2011 -- RI Technologies' (www.researchimpact.com) market insight report on Veterinary Vaccines covers the Types of Veterinary Vaccines and the different Species for which Vaccines are present in the market. The Types of Veterinary Vaccines covered include Live Attenuated, Inactivated, Recombinant and Other (Conjugate Vaccines, DNA Vaccines, Toxoids etc). The Species include Bovine, Porcine, Poultry, Canine & Feline, Ovine & Caprine and Other (Equine, Fish, Wild Animals etc.). The study includes estimations and predictions for the total global Veterinary Vaccines market and also key regional markets including North America, Europe, Asia-Pacific Latin America, Middle East and Rest of World. Business profiles of 13 major companies are discussed in the report. The report serves as a guide to global Veterinary Vaccines industry, covering more than 240 companies that are engaged in the development and supply of Veterinary Vaccines. Information related to recent product releases, product developments, partnerships, collaborations, and mergers and acquisitions is also covered in the report. Exclusive graphically illustrated exhibits (154) complement the text.

Application of genomics and proteomics plays an important role in vaccinology and has resulted in developing new vaccines and also improving the efficiency of present vaccines. Subunit vaccines, recombinant vaccines, DNA vaccines and vectored vaccines are rapidly gaining scientific and public acceptance as the new generation of vaccines and are considered as alternatives to current conventional vaccines. Almost 2000 of the licensed vaccines in the US are killed or live attenuated bacteria or viruses. Development in molecular biology, immunology and genetics has enhanced the production of safer and more effective vaccines. It is also pivotal to formulate and deliver these vaccines appropriately to maximize its potential in pathogenesis and vaccinology.

Immunological research in animal species and means of stimulation of immunity should be intensified greatly. This is made easier with the access to genome sequences of major species such as cattle, dogs, pigs etc. Research on adjuvants which are cable of stimulating innate immunity is also of major importance. The methods of vaccine administration are an important aspect in veterinary vaccinology, especially in the case of vaccines for wild and domestic animals. These animals are not only hosts to identified diseases, but also for potential diseases that have not been identified yet. Certain vaccines are meant only for the preservation of endangered species.

The plant-based vaccine technology works by making plants the production centers of the requisite proteins to develop the vaccines. Thus, these plants become the veritable storehouses for vaccine antigens that include bacteria, viruses and parasites. Another great benefit of the technology is its cost-effectiveness as not much cost is involved in the raising of plants. However, scientists have to keep a watchful eye to allergies to these vaccines. 'The vaccine revolution' known as 'DNA vaccines' is used in protecting disease causing infection. This technique involves inserting of a specific part of pathogen DNA into a living host. The host produces cells that have the ability to make proteins produced by invading pathogens leading to response against the infection. Further advancements include genetic engineering applications to produce edible vaccines. For creating edible vaccines, the genetic material of a plant is changed that helps in synthesizing e.g. Fruit. This is useful for countries lacking storage facilities or staff to administer vaccines to its people. Progression and Cause of veterinary diseases and bacterial components identified can be used as antigens which stimulate the immune response to protect the animals against relevant disease. Vaccines with individual antigens are purer than the existing vaccines (which are killed whole cell bacteria or cultured supernatants containing mixture of chemically inactivated toxins) as they generate an effective and more focused immune response.

About RI Technologies

More information about this report: [http://researchimpact.com/Mir021.aspx]


RI Technologies offers this report at 20% discount now. For customer support, you may please contact RI Technologies - Email: contactus@researchimpact.com / Phone: +91 9676994272


RI Technologies, established in 2006, is a premier source of market research on the Biotechnology & Healthcare sector with exclusive focus on product segments, global and regional market analysis, technology trends, industry outlook, competitor profiles, corporate directory and patents information. The company believes in pure research that will trigger action for immediate customer needs rather than plain reporting of data. The dedicated team works 24/7 to deliver unique reports that are of immense value to investment banks, companies, management consultants, trade associations, corporate executives, business analysts, libraries, universities, and business schools. The company's reports provide strategic information tools to the manufacturers, retailers, distributors, and suppliers that will help them to probe into and support critical business decisions. RI Technologies believes in broadening the value of market research obtained through several dedicated streams of information. The strategic market information tables, graphically represented, will aid companies' research needs and help in forecasting, and gearing up to the future. Emphasis is on factual insights and forecasts with maximum global coverage. The company strives to provide market insight reports that empower customers with enlightening critical business information.

Press Release Source: http://PressExposure.com/PR/RI_Technologies.html

Press Release Submitted On: November 17, 2011 at 3:07 am
This article has been viewed 34060 time(s).